Literature DB >> 22833978

Discussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depression.

Pierre-Michel Llorca1.   

Abstract

Many patients experience discomfort when trying to swallow tablets and capsules, but this issue is rarely discussed between patients and physicians. Discomfort when swallowing pills is common and arises due to the morphology of the oropharynx and esophagus, which are not well suited to swallowing rigid objects of small volume. Compliance with medication is poor in patients with chronic diseases such as depression. An inability or unwillingness to swallow medication can further reduce acceptance of and compliance with medication, which has an impact on effectiveness. Recognition that patient acceptance of prescribed medication is an important component of compliance has led to the development of pill-swallowing training programs and alternative formulations. Orodispersible tablets do not need to be taken with water and can be packaged discreetly in single doses. Orodispersible tablets have been shown to be effective in a number of therapy areas including depression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22833978     DOI: 10.4155/tde.11.32

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  7 in total

1.  Two techniques to make swallowing pills easier.

Authors:  Julia T Schiele; Hendrik Schneider; Renate Quinzler; Gabriele Reich; Walter E Haefeli
Journal:  Ann Fam Med       Date:  2014 Nov-Dec       Impact factor: 5.166

Review 2.  Medication adherence in patients with Parkinson's disease.

Authors:  Naveed Malek; Donald G Grosset
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

3.  Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson's disease: a retrospective claims database analysis.

Authors:  Florent F Richy; Guilhem Pietri; Kimberly A Moran; Emmanuelle Senior; Lydia E Makaroff
Journal:  Appl Health Econ Health Policy       Date:  2013-08       Impact factor: 2.561

4.  A survey of patient preferences for a placebo orodispersible tablet.

Authors:  Alan G Wade; Gordon M Crawford; David Young
Journal:  Patient Prefer Adherence       Date:  2012-03-20       Impact factor: 2.711

5.  Developing drugs for children and the adjustment of medication-is it a new challenge or an adaptation of past ideas?

Authors:  Pascale Gauthier; Jean-Michel Cardot
Journal:  J Pers Med       Date:  2011-12-06

6.  Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication.

Authors:  Nathan Anderson; Andrea G Gillman; Ajay D Wasan
Journal:  J Pain Res       Date:  2020-05-06       Impact factor: 3.133

Review 7.  The Added Value of Liquid Antipsychotics: The Case of Quetiapine.

Authors:  Georgios Papazisis; Spyridon Siafis
Journal:  Curr Clin Pharmacol       Date:  2019
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.